How Healthcare CMOs Are Rethinking AI, Trust and Marketing ROI

Table of Contents

• AI In Healthcare Marketing Has to Start With a Real Problem
• Why Human Oversight Still Matters In AI Workflows
• Evidence Beats Marketing Gloss in High-Stakes Buying Decisions
• AEO Is Still Murky, But Marketers Need to Show Up
• Brevity, Quality and Brand Identity Still Separate the Good From the Generic
• The Most Powerful Marketing Story At Inflow Health Is also the Most Human
• Where AI Is Helping Right Now

The Gist

• Healthcare AI has to solve real workflow failures. Allison Kavanagh says the value of AI in healthcare comes from closing dangerous follow-up gaps, not simply adding more automation or more detection tools.
• Trust still drives modern healthcare marketing. Third-party validation, peer-reviewed evidence, press coverage and face-to-face credibility matter more than polished brand materials alone when selling into clinical and quality leaders.
• More AI content does not guarantee better outcomes. Kavanagh argues that marketers chasing scale need to stay focused on brevity, proof and outcome-driven storytelling instead of flooding the market with more AI-generated material.

Healthcare marketers rarely get the luxury of talking about AI in abstract terms. In Allison Kavanagh’s world, the stakes are immediate, personal and operational. As chief marketing officer at Inflow Health, she works in a category where missed follow-up care is not just a workflow problem or a messaging challenge. It can become a patient safety failure with life-altering consequences.

That reality shapes how Kavanagh thinks about marketing, technology and trust. In our conversation, she connected healthcare AI’s promise to a much tougher standard than novelty. For her, the real question is not whether AI can generate more output. It is whether it can help health systems reduce risk, support clinicians, close dangerous communication gaps and prove value in a market that demands evidence.

AI In Healthcare Marketing Has to Start With a Real Problem

Kavanagh traces her own career through a long-standing focus on applied problem-solving. She began as a writer at Deloitte, where she learned how to communicate complex ideas in terms of value and outcomes, then moved into startups and co-founded an AI healthcare company in 2011 focused on preventable care events. That work centered on a basic but difficult challenge: how to use AI to help push patients toward better outcomes before a crisis happens.

At Inflow Health, that mission shows up in a specific healthcare breakdown: missed follow-up care. Kavanagh explains that when imaging reveals an incidental finding, there is far too much room for the next step to get lost between the chart, the referring provider and the patient. Inflow Health’s pitch is built around using AI to help health systems close those follow-up gaps, reduce administrative burden and improve visibility into what happens after the finding appears.

That means the company’s value proposition extends well beyond technical novelty. Kavanagh positions the offering as a way for healthcare systems to make better sense of increasingly crowded AI environments, especially in radiology, where detection algorithms continue to multiply. Her framing is less about adding yet another tool and more about helping organizations operationalize what they already have, reduce noise and ensure the right actions happen downstream.

Related Article: The Marketing Lesson Inside a Life-Saving Surgical Mission

Why Human Oversight Still Matters In AI Workflows

Even as she makes the case for AI, Kavanagh is careful not to oversell it. One of the strongest themes in her conversation is that AI remains vulnerable to the same system failures and blind spots that frustrate patients every day. When I joked about being billed for an appointment I canceled, Kavanagh used the example to shine a light on a larger point: automation can still produce painful false outcomes when there is no meaningful human oversight built into the process.

That is why she keeps returning to the idea of the human in the loop. In healthcare, she argues, the goal is not to remove people from workflows that affect care. It is to strip away the distracting and administrative parts of the process so clinicians can focus on what they are uniquely equipped to do: guide, clarify, reassure and build trust with patients. AI can help prioritize, surface and route. But the human relationship remains central to the actual care journey.

That perspective also shapes how Kavanagh talks about buyers. In many cases, Inflow Health is selling into chief quality officers, radiology leaders or other stakeholders responsible for systemwide quality and patient safety. Those buyers are not simply looking for efficiency claims. They are weighing liability, risk, workflow disruption, documentation demands and long-term patient impact. For marketers, that raises the bar on how AI stories need to be told.

Evidence Beats Marketing Gloss in High-Stakes Buying Decisions

Kavanagh is especially clear on one point: clinical buyers do not want to hear a polished story unless it is backed by outside proof. Asked what is working in her go-to-market motion, she points first to evidence and third-party validation. Client stories matter, but she says she would rather send a prospect a credible healthcare news article or a peer-reviewed journal piece than rely only on a beautifully designed case study.

That preference reflects both the healthcare buying environment and a broader truth about trust. In categories where the decision can affect patient outcomes, marketers need proof that travels. Press coverage, journals, speaking opportunities and peer voices create assets that can be repurposed across newsletters, sales enablement, one-pagers and broader brand storytelling. For Kavanagh, these are the strategy’s most credible fuel.

That emphasis also lines up with how she defines trust more broadly. Trust is not just a branding aspiration or a soft value statement. It is built through evidence, repeated proof points and the ability to show buyers how a solution reduces risk, improves visibility and produces measurable returns. In the case of Inflow Health, that return includes not only better quality outcomes but recaptured revenue and lower liability exposure when follow-up care is completed instead of missed.

AEO Is Still Murky, But Marketers Need to Show Up

Kavanagh also offered a grounded take on answer engine optimization, one that will sound familiar to many marketing leaders still trying to figure out what success looks like in AI-driven discovery. She is not chasing algorithm tricks, and she does not believe simply optimizing a website for AEO is enough. Instead, she is focused on showing up wherever buyers may be asking early, quiet questions before they ever arrive at a company website.

That distinction matters. Rather than treating AEO as a technical checklist, Kavanagh sees it as an outcome-driven visibility challenge. Buyers may be asking engines how to solve a follow-up care problem or what solutions exist for a specific clinical workflow. If a company is absent from those conversations, it risks disappearing before the formal buying customer journey even begins. For that reason, she says it is critical to distribute expertise beyond owned content and reinforce authority across multiple trusted environments.

At the same time, she warns against assuming that AI means more content is automatically better. That logic failed in the SEO era, and she believes it is just as flawed in the AEO era. The real issue is not speed of production but clarity of value. AI can help marketers scale, but scale without distinctiveness, brevity or proof just adds to the noise.

Related Article: AEO, GEO, SEO: What's the Best Search Playbook?

Brevity, Quality and Brand Identity Still Separate the Good From the Generic

One of Kavanagh’s sharpest observations is that large language models are not naturally good at distilling ideas into something authentically human. They can answer questions, but that is not the same as producing meaningful communication. In her view, marketers need to resist the temptation to flood channels with more AI-assisted material just because the tools make that possible. The better use of AI is in helping teams orchestrate, scale and sharpen what matters most.

That philosophy carries through to her broader view of brand identity. Even as organizations adopt more bots, more models and more automation, she does not believe humans are becoming irrelevant. Instead, she sees AI increasing the importance of human judgment, editorial nuance and brand discipline. The job is not disappearing. The job is becoming more demanding in how it interprets signal, preserves trust and turns fragmented inputs into coherent outcomes.

For proof, Kavanagh points to healthcare itself. She recalled earlier predictions that radiologists would become obsolete because of AI, only for the industry to remain deeply dependent on human expertise. The tools took some work off clinicians’ plates, but interpretation, recommendation and consultation still require people. She sees marketing heading down a similar path. AI may change the workflow, but it does not replace the need for judgment, identity and trust.

The Most Powerful Marketing Story At Inflow Health Is also the Most Human

The deepest trust signal Kavanagh shared had little to do with content strategy or channel mix. It came from the company’s origin story. Many members of the Inflow Health team previously worked with Jill, a nurse whose missed breast lesion was never communicated after she was treated for appendicitis. By the time the issue resurfaced 18 months later during a scheduled mammogram, the cancer had advanced. Kavanagh said the team lost her in 2022.

That story now serves as a moral center for the company. With the family’s permission, Inflow Health has shared it publicly to explain why follow-up gaps matter and why the work cannot be reduced to software language alone. Kavanagh describes it as part of the company’s shared connective tissue — a reminder that quality, trust and humanity are not abstractions. They are obligations shaped by real people and real loss. 

Where AI Is Helping Right Now

For all the caution in Kavanagh’s view, she is not hesitant about using AI where it is clearly useful. When asked where she is seeing the most immediate value in her own marketing work, she pointed to social media creation, management and optimization. It is a practical answer, and maybe the most telling one in the conversation. Rather than framing AI as a sweeping replacement for marketing judgment, she describes it as a tool that is already helping in targeted, repeatable ways.

That may be the clearest takeaway for CMOs trying to balance urgency with discipline. The pressure to embrace AI is real. So is the danger of overstating what it can do. Kavanagh’s approach offers a steadier path: solve a meaningful problem, back every claim with proof, preserve human oversight and use AI where it improves execution without eroding trust.

As marketing leaders head deeper into 2026, Kavanagh’s closing advice is refreshingly simple: “more content doesn’t mean more outcomes.” For teams drowning in tools, dashboards and promises of endless scale, that may be the most useful AI guidance of all.